Your browser doesn't support javascript.
loading
Massively parallel CRISPR off-target detection enables rapid off-target prediction model building.
Tian, Rui; Cao, Chen; He, Dan; Dong, Dirong; Sun, Lili; Liu, Jiashuo; Chen, Ye; Wang, Yuyan; Huang, Zheying; Li, Lifang; Jin, Zhuang; Huang, Zhaoyue; Xie, Hongxian; Zhao, Tingting; Zhong, Chaoyue; Hong, Yongfeng; Hu, Zheng.
Afiliación
  • Tian R; Generulor Co., Ltd., Zhuhai 519000, Guangdong, China. Electronic address: tianruiaiya@gmail.com.
  • Cao C; Department of Obstetrics and Gynecology, Academician Expert Workstation, The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, Hubei, China.
  • He D; Department of Neurology, Zhongnan Hospital of Wuhan University, Wuhan 430071, Hubei, China.
  • Dong D; Department of Gynecologic Oncology, Women and Children's Hospital Affiliated to Zhongnan Hospital of Wuhan University, Wuhan 430071, Hubei, China.
  • Sun L; Department of Gynecologic Oncology, Women and Children's Hospital Affiliated to Zhongnan Hospital of Wuhan University, Wuhan 430071, Hubei, China.
  • Liu J; Department of Gynecological Oncology, the First Affiliated Hospital, Sun Yat-sen University, Guangzhou 510080, Guangdong, China.
  • Chen Y; Department of Gynecological Oncology, the First Affiliated Hospital, Sun Yat-sen University, Guangzhou 510080, Guangdong, China.
  • Wang Y; Department of Gynecological Oncology, the First Affiliated Hospital, Sun Yat-sen University, Guangzhou 510080, Guangdong, China.
  • Huang Z; Department of Gynecological Oncology, the First Affiliated Hospital, Sun Yat-sen University, Guangzhou 510080, Guangdong, China.
  • Li L; Department of Gynecological Oncology, the First Affiliated Hospital, Sun Yat-sen University, Guangzhou 510080, Guangdong, China.
  • Jin Z; Department of Gynecological Oncology, the First Affiliated Hospital, Sun Yat-sen University, Guangzhou 510080, Guangdong, China.
  • Huang Z; Department of Gynecological Oncology, the First Affiliated Hospital, Sun Yat-sen University, Guangzhou 510080, Guangdong, China.
  • Xie H; Generulor Co., Ltd., Zhuhai 519000, Guangdong, China.
  • Zhao T; Generulor Co., Ltd., Zhuhai 519000, Guangdong, China.
  • Zhong C; Generulor Co., Ltd., Zhuhai 519000, Guangdong, China.
  • Hong Y; Generulor Co., Ltd., Zhuhai 519000, Guangdong, China.
  • Hu Z; Department of Gynecologic Oncology, Women and Children's Hospital Affiliated to Zhongnan Hospital of Wuhan University, Wuhan 430071, Hubei, China; Department of Radiation and Medical Oncology, Zhongnan Hospital of Wuhan University, Wuhan 430071, Hubei, China; Hubei Key Laboratory of Tumor Biological
Med ; 4(7): 478-492.e6, 2023 Jul 14.
Article en En | MEDLINE | ID: mdl-37279759

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Infecciones por Papillomavirus / Sistemas CRISPR-Cas Tipo de estudio: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Med Año: 2023 Tipo del documento: Article Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Infecciones por Papillomavirus / Sistemas CRISPR-Cas Tipo de estudio: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Med Año: 2023 Tipo del documento: Article Pais de publicación: Estados Unidos